The management of pregnant patients with antiphospholipid syndrome

@article{Cervera2004TheMO,
  title={The management of pregnant patients with antiphospholipid syndrome},
  author={R. Cervera and J. Balasch},
  journal={Lupus},
  year={2004},
  volume={13},
  pages={683 - 687}
}
Recurrent pregnancy loss is now considered a treatable clinical condition associated with antiphospholipid antibodies. The management of pregnant patients with antiphospholipid syndrome is mainly based on the use of antiaggregant/anticoagulant agents (with aspirin and heparin) to prevent thrombosis in the uteroplacental circulation. Interventions with these drug therapies and monitored pregnancy have increased fetal survival. 
Catastrophic antiphospholipid syndrome: diagnosis and management in pregnancy.
TLDR
Treatment of CAPS is based on expert opinion and relies on a combination of several strategies, including anticoagulation, steroids, plasma exchange sessions, and/or intravenous immunoglobulins. Expand
ANTIPHOSPHOLIPID THROMBOSIS SYNDROME WITH MASSIVE PULMONARY EMBOLISM
TLDR
For the first time in Jordan a young patient with a complete thrombosis of the right pulmonary artery, a raised serum IgG anticardiolipin antibody and a positive lupus anticoagulant is described. Expand
Pregnancy and Catastrophic Antiphospholipid Syndrome
TLDR
Different aspects of obstetric APS features are reviewed, with special emphasis on its life-threatening variant known as catastrophic APS (Asherson’s syndrome) and its relationship with a thrombotic microangiopathy such as HELLP syndrome. Expand
Antiphospholipid syndrome in pregnancy
TLDR
Controversy regarding the appropriateness of anticoagulant use in women with recurrent pregnancy losses and aPLs, and issues surrounding heparin dosing regimens are reviewed. Expand
[The management of pregnant women with antiphospholipid syndrome].
TLDR
Treatment in APS prevents from pregnancy complications and episodes of DVT in susceptible patients, and Administrating in early pregnancy increases chances for life delivery to 80%. Expand
Management of the antiphospholipid syndrome
TLDR
Two randomized prospective studies in patients with antiphospholipid syndrome with initial thromboembolic event support the target international normalized ratio of 2.0 to 3.0 for the prevention of future thrombotic events. Expand
[A case of antiphospholipid syndrome in course of pregnancy and puerperium with lupus-like disease suspicion].
TLDR
The aim of this work was to present a patient with acute primary antiphospholipid syndrome during pregnancy and puerperium, which subsequently was diagnosed as systemic lupus erythematosus flare. Expand
Pregnancy and puerperium are high susceptibility periods for the development of catastrophic antiphospholipid syndrome.
TLDR
This work reviews this specific subset of the catastrophic APS, which can appear during pregnancy or puerperium, and proposes a therapeutical approach for this particular situation. Expand
Anti-phospholipid antibodies and pregnancy
TLDR
Data on perinatal and long-term outcome of children born to patients with antiphospholipid antibodies are reassuring, and despite a significant number of complications still recorded, the large majority of these pregnancies now end with life births. Expand
Síndrome antifosfolipídica e morbidade gestacional Antiphospholipid syndrome and morbidity gestation
The antiphospholipid syndrome (APS) is the commonest cause of acquired thrombophylia in young adults. APS presents as a primary disorder or in association with conective tissue diseases, inExpand
...
1
2
3
...

References

SHOWING 1-10 OF 36 REFERENCES
Management of thrombosis and pregnancy loss in the antiphospholipid syndrome
TLDR
There is now good evidence that patients with antiphospholipid-associated thrombosis will be subject to recurrences and require prophylactic therapy, and there is still doubt regarding the intensity and duration of warfarin therapy. Expand
Reflections on the management of reproductive failure in the antiphospholipid syndrome—the clinician’s perspective
TLDR
A number of controversies in the management of reproductive failure potentially associated with aPL are analyzed in order to help clinicians dealing with such condition in daily clinical practice. Expand
Antiaggregant and anticoagulant therapy in systemic lupus erythematosus and Hughes' syndrome
TLDR
There is still debate regarding the optimal intensity of oral anticoagulation, the best drug combination for pregnancy failure in APS and the management of asymptomatic patients with antiphospholipid antibodies. Expand
Pregnancy: Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome
TLDR
The treatment modality is advocated for prevention of pregnancy losses in patients with the 'obstetric' primary antiphospholipid syndrome who were treated with low-dose aspirin from 1 month before attempting conception and throughout the pregnancy. Expand
Management of Reproductive Failure in the Antiphospholipid Syndrome
TLDR
This chapter presents various management plans for reproductive failure in the antiphospholipid syndrome (APS), and the treatment of the subjects presenting with definite clinical criteria for APS but having low levels of aCL remains controversial in daily clinical practice. Expand
Management of antiphospholipid syndrome during pregnancy.
  • M. Esplin
  • Medicine
  • Clinical obstetrics and gynecology
  • 2001
TLDR
Management plans for pregnancies complicated by antiphospholipid syndrome are outlined, with the assumption that thrombosis in the uteroplacental circulation is the basis for pregnancy loss and other complications in women with APS. Expand
Review : Obstetric outcome in antiphospholipid syndrome
TLDR
A randomised prospective controlled trial is necessary to determine the optimum therapy for pregnancy conservation and thrombprophylaxis in patients with antiphospholipid syndrome. Expand
Obstetric outcome in antiphospholipid syndrome.
TLDR
A randomised prospective controlled trial is necessary to determine the optimum therapy for pregnancy conservation and thrombprophylaxis in patients with antiphospholipid syndrome. Expand
A study of sixty pregnancies in patients with the antiphospholipid syndrome.
TLDR
Close obstetric monitoring by a multidisciplinary team and the use of antithrombotic therapy was effective in reducing the fetal wastage in APS pregnancies despite a high incidence of obstetric and fetal complications. Expand
Guidelines On The Investigation and Management Of The Antiphospholipid Syndrome
TLDR
These revised guidelines on testing for the lupus anticoagulant have been prepared against this background and cover both clinical and laboratory aspects. Expand
...
1
2
3
4
...